Epigenovo is built by a multidisciplinary team with deep expertise in genetics and epigenetics research and a strong foundation in life‑science commercialization and company building. Our team has a proven record of turning complex biology into practical and valuable research tools.
Meet the team
Camilla Huse Bondesson, MBA
CEO & Co-founder
A strategic leader and board professional with global experience in commercialization, governance and venture growth within life science.
Four decades of senior commercial roles, including CEO
Independent consultant since 2004, advising on strategy and commercial execution
Mentor to start‑up teams and active in Chair and board roles since 2013
LinkedIn
camilla@electbio.com
Dr. Xingqi Chen, Assoc. Prof. Uppsala University
CSO & Co-founder
An accomplished Principal Investigator and scientist in genetics and epigenetics, driving breakthroughs in gene regulation and molecular biology.
PhD from Karolisnka Institutet, Sweden
PostDoc from Stanford Univ, USA; Group of Dr. Howard Y. Chang
Co‑inventor on five patents
LinkedIn
Chen Lab
xingqi.chen@igp.uu.se
Frida Henningson Johnson, PhD
Board member
A scientist at heart and a strategist in practice, using that mix to help researchers and innovators navigate real-world challenges.
PhD in Biochemistry from the Swedish Univ. of Veterinary Science
Expertise in biotechnology and genetics as well as in journalism
Commercial experience from product and marketing management
